Antibody-mediated rejection in lung transplantation: turning myth into reality. J Heart Lung Transplant. 2013;32(1):12–3.Glanville AR. Antibody-mediated rejection in lung transplantation: turning myth into reality. J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant. enero de 2013...
Lung Transplant, Acute RejectionLung Transplant, Acute RejectionAcute allograft rejection is defined histologically as a cell-mediated process characterized by perivascular and interstitial mononuclear cell infiltrates composed of T lymphocytes. Antibody-mediated...Pulmonary...
While hyperacute antibody-mediated rejection caused by pre-formed anti-donor antibodies present at the time of transplant is a well established cause of acute graft failure, it is rare. Antibody mediated rejection (AMR) outside that context is now recognized as an important complication in lung ...
Antibody-mediated Rejection of the Lung Practice Essentials Lung transplantation is an accepted modality of treatment for advanced stage lung disease. Since 1988, nearly 40,000 lung transplants and over 1200 heart/lung transplantations have been performed in the Unites States, representing approximately ...
However the role of humoral or antibody- mediated rejection (AMR) in solid organ transplant recipients has become more evident over the years. Antibody mediated rejection has been identified and characterized in other organs but remains poorly defined in lung transplant recipients. No agreed upon ...
None of the lung transplant recipients who had COVID-19–associated ARDS demonstrated antibody-mediated rejection compared with 12.5% in those without COVID-19. At follow-up, all 30 lung transplant recipients who had COVID-19–associated ARDS were alive (median follow-up, 351 days [IQR, 176...
In recent years, the role of humoral immunity in lung rejection has been increasingly appreciated, and antibody-mediated rejection is now recognized as a form of rejection that may result in allograft failure. 展开 关键词: Acute rejection Antibody-mediated rejection Lung transplantation Lymphocytic ...
Alemtuzumab for antibody induction therapy and the treatment of acute cellular rejection in lung transplant (see CPB 0764 - Alemtuzumab (Campath)); AlloSure (donor-derived cell-free DNA testing) for monitoring acute rejection following lung transplantation; Ex-vivo lung perfusion for lung transplantatio...
6. Antibody-mediated rejection after lung transplantation 7. The role of innate immunity in the long-term outcome of lung transplantation 8. Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients 9. Infection prophylaxis and management of fungal infections in...
Evaluation and treatment of antibody-mediated lung transplant rejectionHachem